Roche Funds Large-Scale Bispecific Pair Screening

Company Dualitas Therapeutics / Roche Event Type Research Collaboration and License Platform DualScreen — Functional Bispecific Target-Pair Discovery Indication Immunology and Inflammation (Undisclosed Targets) Summary Roche agreed to pay Dualitas Therapeutics $36.5 million upfront for a research collaboration using Dualitas’ DualScreen platform to functionally test…